These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37368236)

  • 1. Serum total bilirubin level is associated with contrast induced nephropathy after primary percutaneous coronary intervention.
    Özilhan MO; Açıkgöz SK
    Angiology; 2023; 74(10):981-986. PubMed ID: 37368236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
    Yildiz I; Yildiz PO; Rencuzogullari I; Karabag Y; Cagdas M; Burak C; Gurevin MS
    Angiology; 2019 Aug; 70(7):627-632. PubMed ID: 30712366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Çınar T; Tanık VO; Aruğaslan E; Karabağ Y; Çağdaş M; Rencüzoğulları İ; Keskin M
    Cardiovasc Interv Ther; 2019 Jul; 34(3):207-215. PubMed ID: 30191494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Uric Acid to Albumin Ratio Can Predict Contrast-Induced Nephropathy in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
    Şaylık F; Çınar T; Akbulut T; Selçuk M
    Angiology; 2023 Jan; 74(1):70-78. PubMed ID: 35451314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction.
    Liu YH; Liu Y; Zhou YL; He PC; Yu DQ; Li LW; Xie NJ; Guo W; Tan N; Chen JY
    Am J Cardiol; 2016 Jun; 117(12):1896-903. PubMed ID: 27161818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Börekçi A; Gür M; Türkoğlu C; Çaylı M; Selek Ş; Kaypaklı O; Uçar H; Coşkun M; Şeker T; Koç M; Gökdeniz T; Gözükara MY
    Angiology; 2015 Apr; 66(4):339-45. PubMed ID: 24830418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of residual SYNTAX score and SYNTAX revascularization index for contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction.
    Çamci S; Yilmaz E
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5793-5801. PubMed ID: 36066154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-arm blood pressure difference is associated with contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention.
    Simsek Z; Zehir R; Kalkan S; Ceneli D; Alizade E; Bayam E; Candan Ö
    Clin Exp Hypertens; 2022 Apr; 44(3):258-262. PubMed ID: 35060428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Thrombus Burden Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction?
    Sigirci S; Keskin K; Yildiz SS; Cetinkal G; Gurdal A; Kilci H; Tezcan M; Kilickesmez KO
    Angiology; 2019 Aug; 70(7):642-648. PubMed ID: 30621429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Ozturk D; Celik O; Erturk M; Kalkan AK; Uzun F; Akturk IF; Akin F; Yildirim A
    Can J Cardiol; 2016 Feb; 32(2):240-6. PubMed ID: 26255218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Duran M
    Clin Cardiol; 2017 Apr; 40(4):235-242. PubMed ID: 28244599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of contrast-induced nephropathy with bare metal stent restenosis in STEMI patients treated with primary PCI.
    Güngör B; Karataş MB; İpek G; Özcan KS; Çanga Y; Onuk T; Keskin M; Hayıroğlu Mİ; Karadeniz FÖ; Sungur A; Öztürk R; Bolca O
    Ren Fail; 2016 Sep; 38(8):1167-73. PubMed ID: 27436614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Khalfallah M; Allaithy A; Maria DA
    Glob Heart; 2021; 16(1):57. PubMed ID: 34692381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet to Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Sun XP; Li J; Zhu WW; Li DB; Chen H; Li HW; Chen WM; Hua Q
    Angiology; 2018 Jan; 69(1):71-78. PubMed ID: 28464698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum bilirubin with contrast-induced nephropathy and future cardiovascular events in patients undergoing coronary intervention.
    Huang SS; Huang PH; Wu TC; Chen JW; Lin SJ
    PLoS One; 2012; 7(8):e42594. PubMed ID: 22880046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of whole blood viscosity on contrast-induced nephropathy development in patients undergoing percutaneous coronary intervention.
    Kinik M; Çamci S; Ari S; Ari H; Melek M; Bozat T
    Postgrad Med; 2022 Jan; 134(1):78-84. PubMed ID: 34670475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
    Liu YH; Jiang L; Duan CY; He PC; Liu Y; Tan N; Chen JY
    Angiology; 2017 Oct; 68(9):782-789. PubMed ID: 28135823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?
    Ballı M; Taşolar H; Çetin M; Hatem E; Çağlıyan ÇE; Şeker T; Çaylı M
    J Cardiol; 2016 Apr; 67(4):327-30. PubMed ID: 26589269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.